October 22, 2016 2:20 PM ET

Healthcare Equipment and Supplies

Company Overview of Carmell Therapeutics Corporation

Company Overview

Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

3636 Boulevard of the Allies

Pittsburgh, PA 15213

United States

Founded in 2007





Key Executives for Carmell Therapeutics Corporation

Chief Executive Officer and President
Founder and Chief Scientific Officer
Founder and Director
Chief Operating Officer and Director
Compensation as of Fiscal Year 2016.

Carmell Therapeutics Corporation Key Developments

Carmell Therapeutics Announces Management Appointments

Carmell Therapeutics continues to grow and add the necessary management capabilities to advance its products towards US FDA regulatory approval. To successfully advance these programs through the development and commercialization process, Carmell is significantly expanding their senior management capabilities. Joining Randy Hubbell, CEO, and Dr. James Hart, Chief Medical Officer, are: Donna Godward, Chief Quality Officer: Ms. Godward spent most of her career at J&J before retiring as a Chief Quality Officer for J&J's Medical Device and Diagnostic Business. Stephanie Kladakis, PhD, VP of R&D: Dr. Kladakis brings with her over 14 years of experience in product development, from concept through CE Mark and PMA approvals, and was most recently the VP of R&D for Cohera Medical. Janet Vargo, PhD, VP of Clinical Sciences: Dr. Vargo has extensive experience in designing and executing clinical trials and most recently worked at Mentor, LLC (J&J) as Head of Clinical Development and Regulatory Affairs.

Carmell Therapeutics Corporation Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016

Carmell Therapeutics Corporation Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016 . Venue: The Westin Copley Place, 10 Huntington Ave, Boston, MA 02116, United States.

Carmell Therapeutics Appoints James Hart as New Chief Medical Officer

Carmell Therapeutics announced the appointment of Dr. James Hart as its new Chief Medical Officer. Before joining Carmell as its new CMO, Dr. James Hart, MD, FACS, FACC, FACCP has worked with small medical device companies to provide medical and clinical expertise, since his retirement from JNJ (Johnson & Johnson) in February, 2014. Dr. Hart was with J&J for over twelve years with multiple roles of increasing responsibility, being named VP Medical Operations in 2006, Worldwide VP, Evidence Based Medicine and Chief Medical Officer for ETHICON in 2011 and, finally, Chief Medical Officer and VP Medical Affairs for JNJ's Global Surgery Group in 2012. Prior to joining JNJ, Dr. Hart practiced Cardiovascular and Thoracic surgery for 20 years, during which time he was a pioneer in the early evolution of minimally invasive cardiac surgery.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Private Placement
January 22, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Carmell Therapeutics Corporation, please visit www.carmellrx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.